Zevra Therapeutics Inc.
(ZVRA)
undefined
undefined%
At close: undefined
8.38
-1.06%
After-hours Dec 13, 2024, 07:54 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
Revenue | 27.46M | 10.46M | 28.65M | 13.29M | 12.84M | - | - | - | - | - | - | - |
Cost of Revenue | 2.94M | 343.00K | 2.06M | 1.30M | 2.94M | 324.00K | 336.00K | 175.00K | 84.00K | - | - | - |
Gross Profit | 24.52M | 10.12M | 26.59M | 11.98M | 9.89M | -324.00K | -336.00K | -175.00K | -84.00K | - | - | - |
Operating Income | -49.60M | -24.84M | 7.73M | -4.78M | -20.34M | -55.90M | -33.37M | -37.48M | -22.81M | -16.44M | -4.72M | -5.34M |
Interest Income | 4.54M | 760.00K | 248.00K | 89.00K | 309.00K | 420.00K | 365.00K | 353.00K | 32.00K | 4.28K | 52.00K | 34.73K |
Pretax Income | -46.05M | -42.33M | -8.52M | -12.79M | -24.54M | -56.59M | -43.43M | -16.53M | -54.64M | -24.48M | -5.25M | -107.64K |
Net Income | -46.05M | -41.54M | -8.55M | -12.76M | -24.52M | -56.47M | -43.39M | -16.52M | -54.66M | -24.45M | -5.23M | -70.42K |
Selling & General & Admin | 35.09M | 15.34M | 8.70M | 7.92M | 10.82M | 12.51M | 12.77M | 14.00M | 8.88M | 4.53M | 1.35M | 2.34M |
Research & Development | 39.81M | 19.61M | 10.16M | 8.84M | 19.41M | 41.76M | 20.59M | 20.47M | 13.93M | 11.92M | 3.37M | 2.99M |
Other Expenses | -775.00K | - | - | - | - | - | - | - | -31.82M | - | - | - |
Operating Expenses | 74.12M | 34.96M | 18.86M | 16.76M | 30.23M | 54.27M | 33.37M | 34.47M | 22.81M | 16.44M | 4.72M | 142.38K |
Interest Expense | 1.50M | 335.00K | 376.00K | 7.09M | 6.51M | 7.09M | 7.34M | 7.13M | 2.67M | 2.72M | 157.00K | - |
Selling & Marketing Expenses | - | - | - | - | - | - | - | - | - | 93.00 | - | - |
Cost & Expenses | 77.06M | 35.30M | 20.92M | 18.07M | 33.18M | 54.27M | 33.37M | 34.47M | 22.81M | 16.44M | 4.72M | 142.38K |
Income Tax | - | -786.00K | 34.00K | -34.00K | -22.00K | -126.00K | -43.00K | -15.00K | 26.00K | -22.25K | -20.00K | 37.23K |
Shares Outstanding (Basic) | 35.45M | 34.49M | 29.77M | 3.98M | 1.85M | 1.12M | 915.81K | 912.32K | 460.54K | 769.24K | 488.96K | 148.70K |
Shares Outstanding (Diluted) | 35.45M | 34.49M | 29.77M | 3.98M | 1.85M | 1.12M | 915.81K | 912.32K | 460.54K | 769.24K | 488.96K | 148.70K |
EPS (Basic) | -1.3 | -1.2 | -0.29 | -3.21 | -13.23 | -50.39 | -47.37 | -18.1 | -118.69 | -31.79 | -10.69 | -0.47 |
EPS (Diluted) | -1.3 | -1.2 | -0.29 | -3.21 | -13.23 | -50.39 | -47.37 | -18.1 | -118.69 | -31.79 | -10.69 | -0.47 |
EBITDA | -48.60M | -25.53M | -7.89M | -5.43M | -17.73M | -53.94M | -33.03M | -34.30M | -22.73M | -16.37M | -4.65M | 368.89K |
Depreciation & Amortization | 1.01M | 944.00K | 257.00K | 273.00K | 304.00K | 324.00K | 336.00K | 175.00K | 84.00K | 74.76K | 68.00K | 62.56K |